Performance Output With Haptics - Evaluating Athlete Response and Unrealized Potential (POWER-UP)

December 5, 2025 updated by: SuperPatch Limited LLC

POWER-UP Trial (Performance Output With Haptics - Evaluating Athlete Response and Unrealized Potential)

This minimal risk, randomized, double-blind, placebo controlled Institutional Review Board (IRB)-approved observational study with functional measurements, will evaluate athletic performance after use of a drug- free, non-invasive patch (VICTORY Patch; The Super Patch Company Inc.); using KangaTech, Catapult and Force Plates along with crossover control of trials within the same subject group not receiving an 'active' patch.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Emerging technologies that use haptic (skin pressure) technology have been studied and have shown positive improvements in stress levels, balance, sleep, and pain. The VICTORY patch (SuperPatch Company, Toronto, Canada) that also incorporates this technology has shown anecdotal promise to improve athlete performance. With the tools currently in use at the University of Arizona, team coaches and physicians can measure the true impact of neuromuscular changes suggested by the VICTORY patch. This study will measure quadriceps and hamstring strength in isolation as well as peak output in jumping and speed testing within in season training programs with and without VICTORY patch use. When combined with new methods of assessing individual muscle strength (KangaTech) and Force plate as well as Catapult measurements of compound movements of the investigational muscles, the investigators can evaluate the true performance and changes in football athletes with the SuperPatch technology.

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Arizona
      • Tucson, Arizona, United States, 85721
        • University of Arizona

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Adults 18 to 30, inclusive
  2. Able to provide written informed consent
  3. Have received a VICTORY Patch if in treatment group.
  4. Is an athlete on a University of Arizona Varsity Athletic Team
  5. Agree to having physical activity objectively measured for physical activity, as well as attendance, and participation in intervention.
  6. Agree to place an adhesive patch on their skin, as instructed, based on selection group.

Exclusion Criteria:

  1. Use of drugs of abuse (illicit or prescription)
  2. Have an implanted device, or wears, or adheres any electrical device to the body during the study, other than a hearing aid.
  3. Any current medical or musculoskeletal injury that would prohibit athletic participation
  4. Any significant injuries in the last month prior to the intervention that may impact tested performance measures.
  5. New injuries that occur during the course of study testing that may impact performance measures.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Active/Treatment
Data will be collected for athletes prior to first use of patch and then 2-3 days later with the active patch (VICTORY PATCH). Follow-up functional measurements will also be taken at 7 and 9-10 days after baseline with second crossover patch use 9-10 days post-baseline.
Device: VICTORY PATCH
Drug- free, non-invasive patch (VICTORY Patch) with haptic vibrotactile trigger technology (VTT)
Other Names:
  • Haptic Vibrotactile Trigger Technology
  • VTT
Sham Comparator: Non-Active/Control
Data will be collected for athletes prior to first use of patch and then 2-3 days later with the inactive patch. Follow-up functional measurements will also be taken at 7 and 9-10 days after baseline with second crossover patch use 9-10 days post-baseline.
Device: Sham Patch without VTT
Sham Patch without haptic vibrotactile trigger technology (VTT)
Other Names:
  • Sham Comparator
Other: Crossover
Data will be collected for athletes prior to first use of patch and then 2-3 days later with the active or inactive patch. Follow-up functional measurements will also be taken at 7 and 9-10 days after baseline with second crossover patch use 9-10 days post-baseline.
Device: VICTORY PATCH
Drug- free, non-invasive patch (VICTORY Patch) with haptic vibrotactile trigger technology (VTT)
Other Names:
  • Haptic Vibrotactile Trigger Technology
  • VTT
Device: Sham Patch without VTT
Sham Patch without haptic vibrotactile trigger technology (VTT)
Other Names:
  • Sham Comparator

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in subject performance and strength and intensity/interference scores among and between the treated group and the control group for the athlete.
Time Frame: 10 days
Evaluation of change in quadriceps and hamstring function via KangaTech measurements (mm/Kg)
10 days
Changes in subject performance and strength and intensity/interference scores among and between the treated group and the control group for the athlete.
Time Frame: 10 days
Evaluation of change in max power of the Ground Reaction Force (GRF) in quadriceps and hamstring function measured by the Vald force plate (F = m * a ; 1 m/s2).
10 days
Changes in subject performance and strength and intensity/interference scores among and between the treated group and the control group for the athlete.
Time Frame: 10 days
Evaluation of change in subject response to The Borg Rating of Perceived Exertion (RPE) (scale= 1- 10)
10 days
Changes in performance based on patch location or playing position with the VICTORY Patch treatment.
Time Frame: 10 days
Evaluation of performance (overall scores) based on concentration of patch placement among study subjects on either dominant medial forearm or dominant side, or mid-anterior thigh.
10 days
Changes in subject performance and strength and intensity/interference scores among and between the treated group and the control group for the athlete.
Time Frame: 10 days
Evaluation of of Catapult Global Positioning System (GPS) and change in quadriceps and hamstring function to capture maximum acceleration and maximum speed (meters per second (m/s)) during their field workout.
10 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Identification of subject phenotype(s) that will have the optimal response to treatment with the VICTORY Patch, as well as athletes having the least positive response.
Time Frame: 10 days
Evaluation of predictive baseline metrics of playing position and predictive modeling will be used to identify subject phenotype(s) with an optimal, and a least positive, response. The data used as inputs to construct the predictive models will be a collection of the survey results collected from patients at day 0. Optimal and least positive responses will be defined based on changes in performance and other functional measurement scores, and changes in concomitant medications used, in the treatment group between survey dates.
10 days

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Any side effects reported by patients with be documented in athletic training electronic medical record and assessed by team physician and PI
Time Frame: 10 days
Evaluation of reported side effects during study period based on self-report by subject or reported by clinician investigator.
10 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

SuperPatch Limited LLC

Collaborators

University of Arizona
Clarity Science LLC

Investigators

  • Principal Investigator: Mark Sakr, DO, University of Arizona

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 10, 2024

Primary Completion (Actual)

November 1, 2024

Study Completion (Actual)

November 1, 2024

Study Registration Dates

First Submitted

May 10, 2024

First Submitted That Met QC Criteria

May 20, 2024

First Posted (Actual)

May 28, 2024

Study Record Updates

Last Update Posted (Actual)

December 15, 2025

Last Update Submitted That Met QC Criteria

December 5, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • POWER-UP 001

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Muscle Weakness

Clinical Trials on VICTORY PATCH

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kuwait

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe